Roche reports a good start in 2017
Group sales increase 4%1 at constant exchange rates and in Swiss francs. Pharmaceuticals Division sales up 3%, driven mainly by Tecentriq and Perjeta. Diagnostics Division sales grow 6%, primarily ...more
Choose your required content type and access a wide range of materials relating to our company, people, medicines and diagnostic tools.
From idea to medicine - drug development at Roche.